Publications in collaboration with researchers from Saarland University (14)

2024

  1. Antibiotic resistance and tolerance: What can drug delivery do against this global threat?

    Drug Delivery and Translational Research, Vol. 14, Núm. 6, pp. 1725-1734

2018

  1. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

2017

  1. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 118, pp. 62-67

  2. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 119, pp. 361-371

2016

  1. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects

    Journal of Controlled Release, Vol. 223, pp. 207-214

  2. Polyester particles for drug delivery to the skin: Local and systemic applications

    Handbook of Polyester Drug Delivery Systems (Pan Stanford Publishing Pte. Ltd.), pp. 353-377

2012

  1. Set-up of a method using LC-UV to assay mometasone furoate in pharmaceutical dosage forms

    Quimica Nova, Vol. 35, Núm. 4, pp. 818-821

2011

  1. CAN NORTRIPTYLINE BE IMPROVED FOR SMOKING CESSATION BY TRANSDERMAL DELIVERY? A STARTING POINT

    ADVANCES IN MEDICINE AND BIOLOGY, VOL 12 (NOVA SCIENCE PUBLISHERS, INC), pp. 55-68

  2. Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol

    International Journal of Pharmaceutics, Vol. 420, Núm. 1, pp. 147-155

  3. Improved photostability and reduced skin permeation of tretinoin: Development of a semisolid nanomedicine

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 1, pp. 95-101

  4. In Vitro Human Skin Segmentation and Drug Concentration–Skin Depth Profiles

    Methods in Molecular Biology (Humana Press Inc.), pp. 33-50

2010

  1. Wistar rat skin as surrogate for human skin in nortriptyline hydrochloride patch studies

    International Journal of Pharmaceutics, Vol. 384, Núm. 1-2, pp. 137-139

2009

  1. Nortriptyline for smoking cessation: Release and human skin diffusion from patches

    International Journal of Pharmaceutics, Vol. 378, Núm. 1-2, pp. 101-107

2008

  1. Nortriptyline hydrochloride skin absorption: Development of a transdermal patch

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 2, pp. 588-596